The latest issue of ISPOR’s  Values & Outcomes Spotlight looks at the area of aging. We present recent research that highlights what aging contributes to healthcare costs; the importance of coordinated health and social systems to address the challenges of aging; what can be saved in morbidity, mortality, and costs; policy implications; and lastly, the impact of recent advances in the treatment of Alzheimer’s disease and the challenges and implications. 

ISPOR | July/August 2021 Value & Outcomes Spotlight, RESEARCH ROUNDUP

Section Editor: George Papadopoulos.

Read the full article: Research Roundup: July – August, 2021.

About the author:

George Papadopoulos, Partner and Director at Lucid Health Consulting. George is a Health Economist, Pricing and Reimbursement and Strategic Market Access Expert with over 25 years in the healthcare industry in both Australia and USA.  An experienced key speaker and commentator, his current leadership roles include chairman of ARCS Australia and Lecturer at UNSW, Pharmaceutical Medicine.

Connect with George on LinkedIn

The post ISPOR VOS Research RoundUp | July – August 2021 appeared first on Lucid Health Consulting | Experience Matters.

The latest issue of ISPOR’s  Values & Outcomes Spotlight looks at vaccine hesitancy and how this can adversely affect the distribution of the COVID-19 vaccine. Our Director at Lucid Health Consulting, George Papadopoulos, is section editor of the Research Roundup, the articles in this month’s Research Roundup look at the topic of vaccine health economics and outcomes research (HEOR), including the challenges and opportunities presented by COVID-19, accounting for herd immunity and the value of trust in addressing vaccine hesitancy.

ISPOR | January/February 2021 Value & Outcomes Spotlight, RESEARCH ROUNDUP

Section Editor: George Papadopoulos.

Read the full article: Research Roundup – A Gathering of Research Related to Vaccine HEOR

About the author:

George Papadopoulos, Partner and Director at Lucid Health Consulting. George is a Health Economist, Pricing and Reimbursement and Strategic Market Access Expert with over 25 years in the healthcare industry in both Australia and USA.  An experienced key speaker and commentator, his current leadership roles include chairman of ARCS Australia and Lecturer at UNSW, Pharmaceutical Medicine.

Connect with George on LinkedIn

The post ISPOR VOS Research RoundUp | January – February 2021 appeared first on Lucid Health Consulting | Experience Matters.

The articles in this session of Research Roundup look at precision medicine. Precision medicine delivers targeted treatments to specific groups of patients based on individual characteristics. It has held promise for many years as a tailored approach to both disease prevention and treatment that considers the differences in people’s genetic makeup. Genomic sequencing underpins the value of precision medicine in being able to better predict, prevent, diagnose, and treat diseases. Whilst there is an abundance of literature on precision medicine, we have tried to identify recent research that encapsulates these characteristics.

ISPOR | November/December 2020 Value & Outcomes Spotlight, RESEARCH ROUNDUP

Section Editor: George Papadopoulos.

Read the full article: Research RoundUp – Challenges in Precision Medicine: Aiming to Align Data, Value, and Costs

About the author:

George Papadopoulos, Partner and Director at Lucid Health Consulting. George is a Health Economist, Pricing and Reimbursement and Strategic Market Access Expert with over 25 years in the healthcare industry in both Australia and USA.  An experienced key speaker and commentator, his current leadership roles include chairman of ARCS Australia and Lecturer at UNSW, Pharmaceutical Medicine.

Connect with George on LinkedIn

The post ISPOR VOS Research RoundUp | November – December 2020. appeared first on Lucid Health Consulting | Experience Matters.

The articles featured in this issue’s Research Round-Up look at the current state of real-world evidence (RWE). Real-world data (RWD) and RWE are playing an increasing role in healthcare decisions. The healthcare community is using these data to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice, while developers of pharmaceuticals are using RWD and RWE to support clinical trial designs and observational studies to generate innovative and new treatments. 5 research papers have been identified that encapsulate these characteristics and are worth reading.

ISPOR | September/October 2020 Value & Outcomes Spotlight,  RESEARCH ROUNDUP

Section Editor: George Papadopoulos.

Read the full article:    Research Roundup, Using Real-World Evidence in Healthcare Decisions.

About the author:

George Papadopoulos, Partner and Director at Lucid Health Consulting. George is a Health Economist, Pricing and Reimbursement and Strategic Market Access Expert with over 25 years in the healthcare industry in both Australia and USA.  An experienced key speaker and commentator, his current leadership roles include chairman of ARCS Australia and Lecturer at UNSW, Pharmaceutical Medicine.

Connect with George on LinkedIn

The post ISPOR VOS Research RoundUp | September – October 2020. appeared first on Lucid Health Consulting | Experience Matters.

George’s article identifies the interface between experimental and behavioural economics and health economics by identifying and discussing 10 areas of potential debate about behavioural experiments in health. This is reviewed by posing 10 questions to explore these areas and then asking the authors to answer these questions systematically. By using this framework, the authors review the different streams and areas of application of the field of behavioural experiments in health by discussing which significant questions remain to be discussed, and by highlighting the rationale and the scope for the further development of behavioural experiments in health in the years to come.

ISPOR  | July/August 2020 Value & Outcomes Spotlight | RESEARCH ROUNDUP

Section Editor: George Papadopoulos.

“Traditionally, approaches to consumer behaviour have been influenced by standard economic theory and models. These are based on the assumption of human rationality. Behavioural economics draws on psychology and the behavioural sciences in assessing consumer behaviour. This approach postulates that consumers are subject to a range of psychological biases and use various heuristics such as rules-of-thumb, or educated guesses, when making choices. More simply stated, behavioural economics applies economic and psychological principles to overcome barriers to behaviour change. We have identified 4 research papers that encapsulate these characteristics and are worth reading. We, as always, trust you enjoy delving into the research area of behavioural economics and look forward to highlighting new research in the next edition.”

Read the full article:

https://www.ispor.org/docs/default-source/publications/value-outcomes-spotlight/ispor_vos_august-2020_r20_final.pdf?sfvrsn=ae4c7b7_0

The post ISPOR VOS Research RoundUp | July-August 2020. appeared first on Lucid Health Consulting | Experience Matters.

George’s article identifies recent research publications that highlight innovative pricing models for pharmaceuticals and/or medical devices. Highlighting 5 research papers that are worth reading and will hopefully contribute to forming future discussions and debates around innovation, pharmaceuticals, medical devices, and pricing.

ISPOR  | May/June 2020 Value & Outcomes Spotlight.  RESEARCH ROUNDUP

Section Editor: George Papadopoulos.

“In keeping with the theme of this issue, we’ve tried to identify recent research publications that highlight innovative pricing models for pharmaceuticals and/or medical devices. There is a large body of editorial, commentary, and promotional publications, but sparse research, and so in the end it was not an easy task to select the papers for this round. However, there have been some recently published empirical research and conceptualized frameworks, and we have identified 5 research papers that are worth reading. We hope the research highlighted will contribute to a discussion and debate about innovation, pharmaceuticals, medical devices, and pricing.”

Read the full article:

https://www.ispor.org/docs/default-source/publications/value-outcomes-spotlight/may-june2020/research-roundup.pdf?sfvrsn=b6ca417d_0

The post ISPOR VOS Research RoundUp | May- June 2020. appeared first on Lucid Health Consulting | Experience Matters.